Quick Answer
Yubo International Biotech Ltd reported Total Assets of $847.1 thousand for fiscal year 2025.
Yubo International Biotech Ltd Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $847.1K | -44.8% |
| 2024 | $1.53M | -7.9% |
| 2023 | $1.67M | -29.0% |
| 2022 | $2.35M | -48.8% |
| 2021 | $4.59M | +87.6% |
| 2020 | $2.44M | +244387.6% |
| 2020 | $1.0K | -75.0% |
| 2019 | $4.0K | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $953.2K | -42.4% | -9.4% |
| June 30, 2025 | $1.05M | -39.2% | -9.8% |
| March 31, 2025 | $1.17M | -24.7% | -24.0% |
| December 31, 2024 | $1.53M | -7.9% | -7.2% |
| September 30, 2024 | $1.65M | -13.1% | -4.3% |
| June 30, 2024 | $1.73M | -11.9% | +11.6% |
| March 31, 2024 | $1.55M | -26.7% | -7.1% |
| December 31, 2023 | $1.67M | -29.0% | -12.4% |
- Yubo International Biotech Ltd showed a decrease of -44.8% in Total Assets compared to the prior fiscal year.
- Over the 2019–2025 period, Yubo International Biotech Ltd’s total assets has grown by 21077.4% (from $4.0 thousand to $847.1 thousand).
- The most recent figure is from Yubo International Biotech Ltd’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: